Dr. Millie (Millennia) Lytle ND, MPH, CNS 

Abstract

Why optimizing glymphatic drainage is essential for cognitive resilience, detoxification, and the prevention of neurodegenerative and systemic disease.

This clinical commentary explores the glymphatic system as a central yet overlooked detoxification pathway, detailing how impaired brain waste clearance contributes to cognitive decline, toxin accumulation, and chronic disease—and how targeted interventions can restore neurological and systemic health.

Introduction

In the traditional landscape of environmental medicine, clinical protocols have long prioritized the “big three” emunctories: the liver, the kidneys, and the colon. While these pathways are essential for systemic clearance, the naturopathic physician recognizes that detoxification is a symphonic effort. It requires not only the integration of all emunctories—including the skin’s diaphoresis and the vast, often stagnant, lymphatic sea—but also the modulation of the hormonal signals that dictate whether toxins are released from storage cells in the bone and adipose tissue or sequestered in protective holding patterns. Yet, even within this inclusive framework, one organ remains historically overlooked, despite being the most metabolically active and toxin-vulnerable in the human body: the brain.

The “Polluted Mind” describes a measurable physiological state where the brain’s unique waste-clearance architecture—the glymphatic system—fails to keep pace with the modern environmental and surgical burden. To move a patient from reactive survival to neurological resilience, the clinical focus must shift from general systemic support to the specialized mechanics of Glymphatic Waste Clearance. This transition is essential not only for restoring the cognitive faculty required for high-level leadership and long-term health but also for providing a strategic vantage point for the prevention of chronic conditions spanning the spectrum of aging, mood dysregulation, autoimmunity, and neurodegeneration (Ghanizada et al., 2024; Chen, S., et al., 2026).

The Current Clinical Landscape: Limitations and New Horizons

As we refine our understanding of cognitive decline, particularly in the context of Postoperative Cognitive Dysfunction (POCD), the limitations of the current pharmacological model become evident. Evidence-based guidelines now increasingly advocate for multimodal, non-pharmacological strategies as the foundational preventive approach. These include orientation therapy, the rigorous optimization of sleep architecture, and early mobilization (Wildes et al., 2019; Aldecoa et al., 2024).

Currently, high-quality evidence supporting pharmacological interventions to reduce cognitive risk remains remarkably limited. Only a select few agents—namely dexmedetomidine (Dex), melatonin, and sufentanil—have shown promise in clinical settings (Zeng et al., 2023; Zhang et al., 2025). Of these, Dexmedetomidine has emerged as a particularly compelling subject of study. Recent data suggests that its neuroprotective efficacy may be directly linked to its ability to enhance glymphatic circulation, thereby promoting the clearance of neurotoxic metabolites that would otherwise accumulate in the parenchyma (Wang et al., 2024).

This underscores a provocative clinical reality: while the pharmaceutical industry struggles to navigate the Blood-Brain Barrier (BBB), there are currently no validated drugs or devices definitively shown in humans to enhance brain toxin removal during either sleep or wakeful states (Arendash, 2025). This gap highlights the necessity of the naturopathic model of self-purification, honoring the principle of the body’s ability to heal itself—a model would first include, then prioritize the brain’s internal infrastructure to modulate water transport and metabolic waste removal (Chen S., et al., 2025).

Measuring the Invisible: The Glymphatic Toolkit

For decades, the inability to visualize neural waste clearance in-vivo relegated glymphatic health to the realm of theoretical wellness or Eastern medicine concepts. However, we have entered an era where glymphatic function is not only observable but quantifiable. Current measurements utilize sophisticated imaging and fluid dynamics to assess the velocity of the neural flush:

1. Contrast-Enhanced MRI (DCE-MRI): By utilizing gadolinium-based contrast agents injected into the cerebrospinal fluid (CSF), researchers can track the convective movement of fluid through the perivascular spaces. This remains the “gold standard” for observing the bulk flow that defines glymphatic health (Ayyappan et al., 2025).
2. Diffusion Tensor Imaging (DTI-ALPS): A non-invasive breakthrough, the “Analysis along the Perivascular Space” (ALPS) index allows clinicians to estimate glymphatic activity by measuring the diffusivity of water molecules along the deep medullary veins. This index has become a critical biomarker for identifying neurodegenerative risk (Ota et al., 2024; Ayyappan et al., 2025).
3. Near-Infrared Fluorescence Imaging: This emerging tool allows for the visualization of lymphatic drainage from the CNS into the cervical lymph nodes, confirming the vital link between the brain’s internal “wash” and the systemic lymphatic exit (Ayyappan et al., 2025).

Mechanisms of Neural Infiltration: How the Brain Becomes “Polluted”

The central nervous system was historically considered “immuno-privileged,” protected by the BBB as if by a fortress. However, this barrier is far from impenetrable. Neurotoxins reach the brain parenchyma through several sophisticated breaches:

• The Olfactory and Trigeminal Route: The nasal mucosa provides a direct route to the frontal cortex. Fine particulate matter and heavy metals utilize retrograde axonal transport along the olfactory nerves, depositing directly into the seat of executive function (Ghanizada et al., 2024).
• The Inflammatory and Microplastic Leak: Systemic inflammation—often originating in a compromised gut emunctory—releases pro-inflammatory cytokines that increase BBB permeability. This loss of integrity facilitates the infiltration of circulating pollutants, including microplastics and nanoplastics (MNPs). These particles induce oxidative stress and physically obstruct the delicate perivascular spaces required for glymphatic flow (Baroni et al., 2025; Yee et al., 2021).
• Ionic Mimicry & Transport Proteins: Environmental pollutants often “piggyback” on essential nutrient transporters. For instance, lead can mimic calcium, while methylmercury binds to L-type amino acid transporters to cross the BBB (Bridges, et al 2005).

The Science of the Drainage: Convective Flow and Hydrodynamics

The glymphatic system acts as a perivascular “sump pump,” utilizing the convective bulk flow of CSF to eliminate soluble proteins. This process is mediated by Aquaporin-4 (AQP4) water channels on the astrocytic end-feet. The efficiency of this system is highly state-dependent and relies on three pillars: optimal sleep architecture, AQP4 polarization, and cerebrovascular dynamics (Li et al., 2024).

Sleep Architecture and Posture

During deep, non-REM sleep, the brain’s interstitial space expands by approximately 60%, significantly reducing resistance to fluid flow and allowing for the clearance of neurotoxic proteins like amyloid-beta and tau (Xie, L et al, 2013). 

Research demonstrates that the lateral (side-lying) posture is significantly more effective at facilitating waste clearance than supine (which is second) and prone positions (Lee et al., 2015). Furthermore, upright MRI technology reveals that CSF pulse volume increases by 57.6% in the supine position compared to standing (Muccio et al., 2021).

A New Therapeutic Frontier: Wakeful Cleansing and Multisensory Stimulation

While nocturnal sleep remains the primary driver of glymphatic flow, the system is now recognized as an emerging therapeutic approach for a broad spectrum of neurological disorders including Alzheimer’s disease, stroke, meningitis and traumatic brain injury (Gao et al., 2023). This includes the realization that “wakeful” clearance mechanisms exist; structured periods of cognitive downregulation and rest during the day facilitate significant toxin removal, particularly to counter the decline in nighttime flushing that occurs with aging and in Alzheimer’s Disease (Arendash, 2025).

Remarkably, the glymphatic flush can be actively promoted through multisensory gamma stimulation. Research indicates that 40-Hz light and sound stimulation increases the diameter of meningeal lymphatic vessels and promotes the recruitment of AQP4 to astrocytic end-feet, effectively accelerating the clearance of amyloid and other neurotoxic metabolites (Murdock et al., 2024). Furthermore, physical exercise serves as a critical modulator, increasing the expression and polarization of AQP4 channels (Olegário et al., 2024).

Case Illustration: Julian (The Stagnant Executive)

Julian, a high-performing entrepreneur, presented with 

• An average of <5 hours of broken sleep per night, 
• Daily emotional overwhelm and dissatisfaction, 
• Rising visceral adiposity and insulin resistance despite a disciplined 14-hour intermittent fasting window. 
• Clinical investigation revealed a reverse Cortisol Awakening Response on DUTCH Plus, despite near-sufficient cortisol production and high metabolism, and 
• Nighttime Heart Rate Variability (HRV) of 36 ms, indicating profound autonomic dysregulation. 

The clinical audit identified that Julian’s professional obligations were forcing him into a state of glymphatic gridlock. By eating late and working into the melatonin-mediated window, his brain failed to achieve the interstitial expansion required for clearance. This triggered a chronic cortisol response that facilitated a “holding pattern” of adipose-stored waste material, resulting in weight-loss resistance and mental and physical exhaustion.

The intervention focused on an earlier fasting window, an earlier bedtime, and the restoration of the wash cycle through:

• Circadian Anchoring: Morning sunlight to set to the circadian rhythm and sunrise (Chen, P. et al., 2026).
• Phosphatidylserine 100mg at 10pm to prevent nighttime cortisol spikes. Wakeful Rest: Prescribing “intermittent rest” with HeartMath Sensor intervals to facilitate day-time toxin removal (Arendash, 2025) and improve HRV.
• Mineral Support: Oral zinc, and magnesium-arginine applications to relax the cervical musculature, clearing the lymphatic exit. Serum zinc is a significant independent predictor of brain clearance system activity (the DTI-ALPS index). Optimal zinc levels are required to facilitate neuroprotective clearance (Ota et al., 2024).

Within weeks, Julian’s HRV improved to the 50s and his visceral fat began to mobilize. His success was not the result of more force, but the strategic restoration of his internal clearance processes.

Clinical Strategy: The Glymphatic Flush Protocol

Additional therapeutics to restore glymphatic velocity, the clinician must address the biochemical and mechanical prerequisites of the CNS emunctory:

1. Multisensory Modulation: Utilizing 40-Hz gamma stimulation with Alzheimer’s Lights or binaural beats can actively promote glymphatic clearance and lymphatic vessel diameter (Murdock et al., 2024).
2. Exercise: Aerobic activity optimizes AQP4 polarization for deep-sleep clearance (Olegário et al., 2024).
3. Managing the Surgical Recovery: For patients undergoing procedures, the use of Dexmedetomidine should be considered for its ability to enhance glymphatic circulation and mitigate POCD risk (Wang et al., 2024; Zhang et al., 2025).
4. Phosphatidylcholine supports the structural integrity of the very cell membranes (astrocytic end-feet) where the AQP4 channels reside, potentially aiding the physical mechanism of the flush.

Conclusion: Integrating the CNS Emunctory

The future of environmental medicine lies in the integration of the CNS emunctory into standard detoxification maps. By addressing the glymphatic system alongside the traditional emunctories—liver, kidneys, skin, and lymph—we provide a pathway for patients to clear the physiological stagnation of the “Polluted Mind,” optimizing the infrastructure innate for daily neurological renewal.

Clinical Commentary: The Top-Down Detoxification Strategy

In the traditional emunctory model, we often work upstream, addressing the gut and liver to eventually “clear the head.” However, the emerging science of the glymphatic system necessitates a downstream detoxification strategy.

If the central emunctory is stagnant, the metabolic exhaust of the most active organ in the body remains sequestered, regardless of how efficient the liver or colon may be. A top-down approach recognizes that:

1. Neurological Priority: The brain’s “self-purification” is the most time-sensitive and state-dependent process in the body. If the glymphatic flush is inhibited, systemic detoxification is inherently incomplete.
2. Pressure Gradients: By prioritizing the CNS exit and glymphatic velocity, we reduce the backpressure on the BBB. This allows the body to move waste out of deep storage (bone and adipose) and into the systemic circulation only when the neural emunctories are open.
3. Hormonal Precedence: By first anchoring the circadian and stress-response systems (upstream), we signal the body to shift from toxic sequestration to active mobilization downstream.

Implementing this model means we no longer view “brain fog” as a downstream symptom of a sluggish liver; we view glymphatic stagnation as an upstream driver of systemic metabolic failure. The root cause of a headache is no longer merely the liver; it is the brain’s capacity for drainage, leaving the liver to function as the vital downstream workhorse.

---

Millie (Millennia) Lytle, ND, MPH, CNS is a licensed naturopathic doctor, certified nutrition specialist, and public health professional specializing in environmental medicine, women’s health, and complex chronic illness. She earned her Doctor of Naturopathic Medicine degree from Bastyr University, a Master of Public Health from the University of Washington, and holds certification through the Board for Certification of Nutrition Specialists (CNS).

Dr. Lytle’s clinical and research focus centers on environmental toxicology, detoxification pathways, and the impact of chemical exposures on endocrine, immune, and metabolic health. She integrates functional laboratory assessment, nutritional therapeutics, botanical medicine, and lifestyle interventions to address conditions such as hormone imbalance, thyroid dysfunction, autoimmune disease, and environmentally mediated illness.

In addition to her clinical work, Dr. Lytle is an educator, researcher, and science communicator, contributing to professional training programs and public health initiatives focused on reducing toxic burden and optimizing long-term health. She is committed to bridging naturopathic medicine, nutrition science, and environmental health to support individualized, evidence-informed care.

---

References:

1. Aldecoa, C., Bettelli, G., Bilotta, F., Sanders, R. D., Audisio, R., Borozdina, A., … & Spies, C. (2024). European Society of Anaesthesiology and Intensive Care evidence-based and consensus-based guideline on postoperative delirium. European Journal of Anaesthesiology, 41(2), 81–108. https://pubmed.ncbi.nlm.nih.gov/37599617/
2. Arendash, G. W. (2025). The brain toxin cleansing of sleep achieved during wakefulness. Journal of Neurorestoratology, 13(1), 100115. https://pubmed.ncbi.nlm.nih.gov/39941597/
3. Ayyappan, K., et al. (2025). Measuring glymphatic function: Assessing the toolkit. Neural Regeneration Research, 20(2), 534–541. https://pmc.ncbi.nlm.nih.gov/articles/PMC12220680/
4. Baroni, A., Moulton, C., Cristina, M., Sansone, L., Belli, M., & Tasciotti, E. (2025). Nano- and Microplastics in the Brain: An Emerging Threat to Neural Health. Nanomaterials (Basel, Switzerland), 15(17), 1361. https://doi.org/10.3390/nano15171361
5. Bridges, C. C., & Zalups, R. K. (2005). Molecular and ionic mimicry and the transport of toxic metals. Toxicology and applied pharmacology, 204(3), 274–308. https://doi.org/10.1016/j.taap.2004.09.007. 
6. Chen, P., Chen, G., Guo, Z., et al. (2026). Bright light therapy influences glymphatic system function in individuals with subthreshold depression: A randomized clinical trial. Brain, Behavior, and Immunity, 134, 106484. https://pubmed.ncbi.nlm.nih.gov/41672157/
7. Chen, S., et al. (2023). Glymphatic system: A self-purification circulation in brain. Frontiers in Molecular Neuroscience, 16, 1186134. https://pmc.ncbi.nlm.nih.gov/articles/PMC10359151/
8. Gao, Y., et al. (2023). Glymphatic system: An emerging therapeutic approach for neurological disorders. Frontiers in Aging Neuroscience, 15, 1167444. https://pmc.ncbi.nlm.nih.gov/articles/PMC10359151/
9. Ghanizada, H., et al. (2024). The glymphatic system: A review of its role in central nervous system waste clearance and neurological disease. Journal of Neuroinflammation, 21(1), 40. https://pubmed.ncbi.nlm.nih.gov/40122623/
10. Jessen, N. A., Munk, A. S., Lundgaard, I., & Nedergaard, M. (2015). The glymphatic system: A beginner’s guide. Neurochemical Research, 40(12), 2583–2599. https://pmc.ncbi.nlm.nih.gov/articles/PMC4636982/
11. Lee, H., Xie, L., Yu, M., Kang, H., Feng, T., Deane, R., Logan, J., Nedergaard, M., & Benveniste, H. (2015). The effect of body posture on brain glymphatic transport. Journal of Neuroscience, 35(31), 11033–11044. https://pubmed.ncbi.nlm.nih.gov/26245965/
12. Muccio, M., Chu, D., Minkoff, L., & Koberina, M. (2021). Upright MRI reveals posture-related changes in CSF pulse volume. Frontiers in Cell and Developmental Biology, 9, 658604. https://pmc.ncbi.nlm.nih.gov/articles/PMC8710028/
13. Murdock, M. H., et al. (2024). Multisensory gamma stimulation promotes glymphatic clearance of amyloid. Nature, 627(8002), 149–156. https://www.nature.com/articles/s41586-024-07132-6
14. Olegário, R. L., et al. (2024). The newly discovered glymphatic system: The missing link between physical exercise and brain health? Frontiers in Molecular Neuroscience, 17, 1361245. https://pmc.ncbi.nlm.nih.gov/articles/PMC11058641/
15. Ota, S., Matsushita, S., Ito, K., et al. (2024). Brain clearance system activity and serum zinc levels in healthy participants. Scientific Reports, 14(1), 27443. https://pmc.ncbi.nlm.nih.gov/articles/PMC11845861/
16. Plog, B. A., Dashnaw, M. L., Hitomi, E., Peng, W., Liao, Y., Lou, N., … & Nedergaard, M. (2015). Biomarkers of traumatic injury are transported from brain to blood via the glymphatic system. The Journal of Neuroscience, 35(2), 518–526. https://pubmed.ncbi.nlm.nih.gov/25589747/
17. Wang, S., Yu, X., Cheng, L., Ren, W., Wen, G., Wu, X., Lou, H., Ren, X., Lu, L., Hermenean, A., Yao, J., Li, B., Lu, Y., & Wu, X. (2024). Dexmedetomidine improves the circulatory dysfunction of the glymphatic system induced by sevoflurane through the PI3K/AKT/ΔFosB/AQP4 pathway in young mice. Cell death & disease, 15(6), 448. https://doi.org/10.1038/s41419-024-06845-w
18. Wildes, T. S., et al. (2019). Effect of electroencephalography-guided anesthetic administration on postoperative delirium among older adults undergoing major surgery: A randomized clinical trial. JAMA, 321(5), 473–483. https://pubmed.ncbi.nlm.nih.gov/30721296/
19. Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., Takano, T., Deane, R., & Nedergaard, M. (2013). Sleep drives metabolite clearance from the adult brain. Science (New York, N.Y.), 342(6156), 373–377. https://pmc.ncbi.nlm.nih.gov/articles/PMC3880190/
20. Yee, M. S., Hii, L. W., Loke, C. K., et al. (2021). Impact of microplastics and nanoplastics on human health. Nanomaterials, 11(2), 496. https://pmc.ncbi.nlm.nih.gov/articles/PMC7920297/
21. Zhang, S. S., et al. (2025). Dexmedetomidine and the glymphatic system: A new perspective in managing postoperative cognitive dysfunction. Frontiers in Pharmacology, 16, 1648308. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1648308/full